• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    10/23/24 4:06:46 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    algn-20241023
    0001097149false00010971492024-10-232024-10-23


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 23, 2024

    ALIGN TECHNOLOGY, INC.
    (Exact name of registrant as specified in its charter)
    Delaware000-3225994-3267295
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

    410 North Scottsdale Road, Suite 1300, Tempe, Arizona 85288
    (Address of principal executive offices) (Zip Code)
    (602) 742-2000
    (Registrant’s telephone number, including area code)

    Not applicable
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, $0.0001 par valueALGNThe NASDAQ Stock Market LLC
    (NASDAQ Global Select Market)
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17  CFR §240.12b-2). 
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







    Item 2.02    Results of Operations and Financial Condition.

    On October 23, 2024, Align Technology, Inc. issued a press release and will hold a conference call regarding its financial results for its third quarter ended September 30, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

    This information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

    Item 9.01    Financial Statements and Exhibits.

    (d) Exhibits

    Exhibit No.Description
    99.1
    Press Release of Align Technology, Inc. announcing its third quarter ended September 30, 2024 financial results
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)






    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    ALIGN TECHNOLOGY, INC.
    By:/s/ John F. Morici
    John F. Morici
    Chief Financial Officer and Executive Vice President, Global Finance

    Date: October 23, 2024







    Get the next $ALGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    10/27/2023$200.00Buy → Neutral
    UBS
    More analyst ratings

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Align Technology Announces New $1 Billion Stock Repurchase Program

      Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has authorized a new stock repurchase program. Under the new program, Align may purchase up to $1.0 billion of its common stock over the next three years. The company's prior $1 billion authorization approved in January 2023 was completed on May 1, 2025 (with settlement on May 2, 2025). "We are pleased to announce that our Board of Directors has authorized a new $1 billion sto

      5/6/25 9:00:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Speak at Upcoming Financial Conferences

      Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: Bank of America 2025 Healthcare Conference Date: Tuesday, May 13, 2025

      5/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Align Tech downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

      4/25/25 8:29:20 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Wells Fargo initiated coverage on Align Tech with a new price target

      Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

      2/14/25 7:02:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Tech upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously

      1/6/25 7:28:53 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      8/19/24 6:35:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,845 worth of shares (5,194 units at $192.50), increasing direct ownership by 3% to 208,664 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/9/23 8:35:10 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,972 worth of shares (5,319 units at $188.00), increasing direct ownership by 3% to 203,470 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/1/23 5:18:50 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Financials

    Live finance-specific insights

    See more
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Announce First Quarter 2025 Results on April 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

      4/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results

      Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA

      2/5/25 4:05:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/13/24 4:59:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/24 4:31:42 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/23 11:07:31 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann converted options into 3,341 shares and covered exercise/tax liability with 965 shares, increasing direct ownership by 51% to 7,068 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:47:20 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP GLOBAL HR Hockridge Stuart A converted options into 2,587 shares and covered exercise/tax liability with 696 shares, increasing direct ownership by 20% to 11,558 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:46:27 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP & CHIEF FINANCIAL OFFICER Morici John converted options into 4,539 shares and covered exercise/tax liability with 1,509 shares, increasing direct ownership by 23% to 16,023 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:45:47 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    SEC Filings

    See more
    • SEC Form 10-Q filed by Align Technology Inc.

      10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/8/25 5:14:03 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/6/25 9:00:29 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      4/30/25 4:06:37 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    See more
    • Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

      Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

      3/25/25 4:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

      5/22/24 5:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

      2/8/23 4:55:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care